Cara Therapeutics Inc (CARA)
0.69
-0.04
(-5.72%)
USD |
NASDAQ |
Apr 18, 16:00
0.70
+0.01
(+1.45%)
After-Hours: 20:00
Cara Therapeutics Max Drawdown (5Y): 98.22% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 98.22% |
| February 29, 2024 | 98.22% |
| January 31, 2024 | 98.18% |
| December 31, 2023 | 97.96% |
| November 30, 2023 | 96.81% |
| October 31, 2023 | 96.37% |
| September 30, 2023 | 94.28% |
| August 31, 2023 | 91.20% |
| July 31, 2023 | 91.13% |
| June 30, 2023 | 90.30% |
| May 31, 2023 | 89.11% |
| April 30, 2023 | 86.54% |
| March 31, 2023 | 83.25% |
| February 28, 2023 | 74.48% |
| January 31, 2023 | 74.48% |
| December 31, 2022 | 74.48% |
| November 30, 2022 | 74.48% |
| October 31, 2022 | 74.48% |
| September 30, 2022 | 74.48% |
| August 31, 2022 | 74.48% |
| July 31, 2022 | 74.48% |
| June 30, 2022 | 74.48% |
| May 31, 2022 | 74.48% |
| April 30, 2022 | 70.13% |
| March 31, 2022 | 66.16% |
| Date | Value |
|---|---|
| February 28, 2022 | 66.16% |
| January 31, 2022 | 66.16% |
| December 31, 2021 | 66.16% |
| November 30, 2021 | 66.16% |
| October 31, 2021 | 66.16% |
| September 30, 2021 | 66.16% |
| August 31, 2021 | 74.30% |
| July 31, 2021 | 74.30% |
| June 30, 2021 | 76.79% |
| May 31, 2021 | 76.79% |
| April 30, 2021 | 78.93% |
| March 31, 2021 | 80.50% |
| February 28, 2021 | 80.50% |
| January 31, 2021 | 80.50% |
| December 31, 2020 | 80.50% |
| November 30, 2020 | 80.50% |
| October 31, 2020 | 80.50% |
| September 30, 2020 | 80.50% |
| August 31, 2020 | 80.50% |
| July 31, 2020 | 80.50% |
| June 30, 2020 | 80.50% |
| May 31, 2020 | 80.50% |
| April 30, 2020 | 80.50% |
| March 31, 2020 | 80.50% |
| February 29, 2020 | 80.50% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
66.16%
Minimum
Sep 2021
98.22%
Maximum
Feb 2024
80.04%
Average
80.50%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
| Nektar Therapeutics | 99.30% |
| Stereotaxis Inc | 86.04% |
| Cerus Corp | 85.40% |
| Avid Bioservices Inc | 86.42% |
| Rigel Pharmaceuticals Inc | 86.40% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -57.05 |
| Beta (5Y) | 0.7022 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 72.86% |
| Historical Sharpe Ratio (5Y) | -0.6573 |
| Historical Sortino (5Y) | -0.9872 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.72% |